Copyright Reports & Markets. All rights reserved.

Global High Potency Active Pharmaceutical Ingredients (APIs) Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of High Potency Active Pharmaceutical Ingredients (APIs)

      • 1.1 Definition of High Potency Active Pharmaceutical Ingredients (APIs)
      • 1.2 High Potency Active Pharmaceutical Ingredients (APIs) Segment by Type
        • 1.2.1 Global High Potency Active Pharmaceutical Ingredients (APIs) Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Synthetic
        • 1.2.3 Biotech
      • 1.3 High Potency Active Pharmaceutical Ingredients (APIs) Segment by Applications
        • 1.3.1 Global High Potency Active Pharmaceutical Ingredients (APIs) Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Oncology
        • 1.3.3 Hormonal
        • 1.3.4 Glaucoma
        • 1.3.5 Others
      • 1.4 Global High Potency Active Pharmaceutical Ingredients (APIs) Overall Market
        • 1.4.1 Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue (2014-2025)
        • 1.4.2 Global High Potency Active Pharmaceutical Ingredients (APIs) Production (2014-2025)
        • 1.4.3 North America High Potency Active Pharmaceutical Ingredients (APIs) Status and Prospect (2014-2025)
        • 1.4.4 Europe High Potency Active Pharmaceutical Ingredients (APIs) Status and Prospect (2014-2025)
        • 1.4.5 China High Potency Active Pharmaceutical Ingredients (APIs) Status and Prospect (2014-2025)
        • 1.4.6 Japan High Potency Active Pharmaceutical Ingredients (APIs) Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia High Potency Active Pharmaceutical Ingredients (APIs) Status and Prospect (2014-2025)
        • 1.4.8 India High Potency Active Pharmaceutical Ingredients (APIs) Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of High Potency Active Pharmaceutical Ingredients (APIs)
      • 2.3 Manufacturing Process Analysis of High Potency Active Pharmaceutical Ingredients (APIs)
      • 2.4 Industry Chain Structure of High Potency Active Pharmaceutical Ingredients (APIs)

      3 Development and Manufacturing Plants Analysis of High Potency Active Pharmaceutical Ingredients (APIs)

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global High Potency Active Pharmaceutical Ingredients (APIs) Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of High Potency Active Pharmaceutical Ingredients (APIs)
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 High Potency Active Pharmaceutical Ingredients (APIs) Production and Capacity Analysis
      • 4.2 High Potency Active Pharmaceutical Ingredients (APIs) Revenue Analysis
      • 4.3 High Potency Active Pharmaceutical Ingredients (APIs) Price Analysis
      • 4.4 Market Concentration Degree

      5 High Potency Active Pharmaceutical Ingredients (APIs) Regional Market Analysis

      • 5.1 High Potency Active Pharmaceutical Ingredients (APIs) Production by Regions
        • 5.1.1 Global High Potency Active Pharmaceutical Ingredients (APIs) Production by Regions
        • 5.1.2 Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Regions
      • 5.2 High Potency Active Pharmaceutical Ingredients (APIs) Consumption by Regions
      • 5.3 North America High Potency Active Pharmaceutical Ingredients (APIs) Market Analysis
        • 5.3.1 North America High Potency Active Pharmaceutical Ingredients (APIs) Production
        • 5.3.2 North America High Potency Active Pharmaceutical Ingredients (APIs) Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America High Potency Active Pharmaceutical Ingredients (APIs) Import and Export
      • 5.4 Europe High Potency Active Pharmaceutical Ingredients (APIs) Market Analysis
        • 5.4.1 Europe High Potency Active Pharmaceutical Ingredients (APIs) Production
        • 5.4.2 Europe High Potency Active Pharmaceutical Ingredients (APIs) Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe High Potency Active Pharmaceutical Ingredients (APIs) Import and Export
      • 5.5 China High Potency Active Pharmaceutical Ingredients (APIs) Market Analysis
        • 5.5.1 China High Potency Active Pharmaceutical Ingredients (APIs) Production
        • 5.5.2 China High Potency Active Pharmaceutical Ingredients (APIs) Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China High Potency Active Pharmaceutical Ingredients (APIs) Import and Export
      • 5.6 Japan High Potency Active Pharmaceutical Ingredients (APIs) Market Analysis
        • 5.6.1 Japan High Potency Active Pharmaceutical Ingredients (APIs) Production
        • 5.6.2 Japan High Potency Active Pharmaceutical Ingredients (APIs) Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan High Potency Active Pharmaceutical Ingredients (APIs) Import and Export
      • 5.7 Southeast Asia High Potency Active Pharmaceutical Ingredients (APIs) Market Analysis
        • 5.7.1 Southeast Asia High Potency Active Pharmaceutical Ingredients (APIs) Production
        • 5.7.2 Southeast Asia High Potency Active Pharmaceutical Ingredients (APIs) Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia High Potency Active Pharmaceutical Ingredients (APIs) Import and Export
      • 5.8 India High Potency Active Pharmaceutical Ingredients (APIs) Market Analysis
        • 5.8.1 India High Potency Active Pharmaceutical Ingredients (APIs) Production
        • 5.8.2 India High Potency Active Pharmaceutical Ingredients (APIs) Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India High Potency Active Pharmaceutical Ingredients (APIs) Import and Export

      6 High Potency Active Pharmaceutical Ingredients (APIs) Segment Market Analysis (by Type)

      • 6.1 Global High Potency Active Pharmaceutical Ingredients (APIs) Production by Type
      • 6.2 Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Type
      • 6.3 High Potency Active Pharmaceutical Ingredients (APIs) Price by Type

      7 High Potency Active Pharmaceutical Ingredients (APIs) Segment Market Analysis (by Application)

      • 7.1 Global High Potency Active Pharmaceutical Ingredients (APIs) Consumption by Application
      • 7.2 Global High Potency Active Pharmaceutical Ingredients (APIs) Consumption Market Share by Application (2014-2019)

      8 High Potency Active Pharmaceutical Ingredients (APIs) Major Manufacturers Analysis

      • 8.1 Lonza
        • 8.1.1 Lonza High Potency Active Pharmaceutical Ingredients (APIs) Production Sites and Area Served
        • 8.1.2 Lonza Product Introduction, Application and Specification
        • 8.1.3 Lonza High Potency Active Pharmaceutical Ingredients (APIs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Novartis International AG
        • 8.2.1 Novartis International AG High Potency Active Pharmaceutical Ingredients (APIs) Production Sites and Area Served
        • 8.2.2 Novartis International AG Product Introduction, Application and Specification
        • 8.2.3 Novartis International AG High Potency Active Pharmaceutical Ingredients (APIs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 BASF AG
        • 8.3.1 BASF AG High Potency Active Pharmaceutical Ingredients (APIs) Production Sites and Area Served
        • 8.3.2 BASF AG Product Introduction, Application and Specification
        • 8.3.3 BASF AG High Potency Active Pharmaceutical Ingredients (APIs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Carbogen Amcis AG
        • 8.4.1 Carbogen Amcis AG High Potency Active Pharmaceutical Ingredients (APIs) Production Sites and Area Served
        • 8.4.2 Carbogen Amcis AG Product Introduction, Application and Specification
        • 8.4.3 Carbogen Amcis AG High Potency Active Pharmaceutical Ingredients (APIs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Eli Lilly and Company
        • 8.5.1 Eli Lilly and Company High Potency Active Pharmaceutical Ingredients (APIs) Production Sites and Area Served
        • 8.5.2 Eli Lilly and Company Product Introduction, Application and Specification
        • 8.5.3 Eli Lilly and Company High Potency Active Pharmaceutical Ingredients (APIs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Teva Pharmaceutical Industries Ltd
        • 8.6.1 Teva Pharmaceutical Industries Ltd High Potency Active Pharmaceutical Ingredients (APIs) Production Sites and Area Served
        • 8.6.2 Teva Pharmaceutical Industries Ltd Product Introduction, Application and Specification
        • 8.6.3 Teva Pharmaceutical Industries Ltd High Potency Active Pharmaceutical Ingredients (APIs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Bristol-Myers Squibb
        • 8.7.1 Bristol-Myers Squibb High Potency Active Pharmaceutical Ingredients (APIs) Production Sites and Area Served
        • 8.7.2 Bristol-Myers Squibb Product Introduction, Application and Specification
        • 8.7.3 Bristol-Myers Squibb High Potency Active Pharmaceutical Ingredients (APIs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Pfizer Inc.
        • 8.8.1 Pfizer Inc. High Potency Active Pharmaceutical Ingredients (APIs) Production Sites and Area Served
        • 8.8.2 Pfizer Inc. Product Introduction, Application and Specification
        • 8.8.3 Pfizer Inc. High Potency Active Pharmaceutical Ingredients (APIs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Roche Diagnostics.
        • 8.9.1 Roche Diagnostics. High Potency Active Pharmaceutical Ingredients (APIs) Production Sites and Area Served
        • 8.9.2 Roche Diagnostics. Product Introduction, Application and Specification
        • 8.9.3 Roche Diagnostics. High Potency Active Pharmaceutical Ingredients (APIs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Hospira Inc
        • 8.10.1 Hospira Inc High Potency Active Pharmaceutical Ingredients (APIs) Production Sites and Area Served
        • 8.10.2 Hospira Inc Product Introduction, Application and Specification
        • 8.10.3 Hospira Inc High Potency Active Pharmaceutical Ingredients (APIs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Boehringer Ingelheim
      • 8.12 Covidien Plc
      • 8.13 Merck & Co
      • 8.14 Bayer AG
      • 8.15 Sigma-Aldrich Corporation
      • 8.16 Sanofi Aventis.

      9 Development Trend of Analysis of High Potency Active Pharmaceutical Ingredients (APIs) Market

      • 9.1 Global High Potency Active Pharmaceutical Ingredients (APIs) Market Trend Analysis
        • 9.1.1 Global High Potency Active Pharmaceutical Ingredients (APIs) Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 High Potency Active Pharmaceutical Ingredients (APIs) Regional Market Trend
        • 9.2.1 North America High Potency Active Pharmaceutical Ingredients (APIs) Forecast 2019-2025
        • 9.2.2 Europe High Potency Active Pharmaceutical Ingredients (APIs) Forecast 2019-2025
        • 9.2.3 China High Potency Active Pharmaceutical Ingredients (APIs) Forecast 2019-2025
        • 9.2.4 Japan High Potency Active Pharmaceutical Ingredients (APIs) Forecast 2019-2025
        • 9.2.5 Southeast Asia High Potency Active Pharmaceutical Ingredients (APIs) Forecast 2019-2025
        • 9.2.6 India High Potency Active Pharmaceutical Ingredients (APIs) Forecast 2019-2025
      • 9.3 High Potency Active Pharmaceutical Ingredients (APIs) Market Trend (Product Type)
      • 9.4 High Potency Active Pharmaceutical Ingredients (APIs) Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 High Potency Active Pharmaceutical Ingredients (APIs) Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        High Potency Active Pharmaceutical Ingredients (APIs) have higher active level targeting sever diseases such as tumour cells, infected cells, damaged organs than regular medicine elements.
        Highly potent APIs are capable of targeting diseased cell selectively and more precisely than other compounds. Increasing incidence of cancer resulted in increasing R&D pertaining to anticancer drugs which thereby propelling the demand for HPAPIs over the forecast period. In addition, rising usage of HPAPI in gynecology & cosmetics are accounted for the further growth.

        The global High Potency Active Pharmaceutical Ingredients (APIs) market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on High Potency Active Pharmaceutical Ingredients (APIs) volume and value at global level, regional level and company level. From a global perspective, this report represents overall High Potency Active Pharmaceutical Ingredients (APIs) market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of High Potency Active Pharmaceutical Ingredients (APIs) in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their High Potency Active Pharmaceutical Ingredients (APIs) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Lonza
        Novartis International AG
        BASF AG
        Carbogen Amcis AG
        Eli Lilly and Company
        Teva Pharmaceutical Industries Ltd
        Bristol-Myers Squibb
        Pfizer Inc.
        Roche Diagnostics.
        Hospira Inc
        Boehringer Ingelheim
        Covidien Plc
        Merck & Co
        Bayer AG
        Sigma-Aldrich Corporation
        Sanofi Aventis.

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Synthetic
        Biotech

        Segment by Application
        Oncology
        Hormonal
        Glaucoma
        Others

        Buy now